MNVRX
Price
$30.90
Change
-$0.89 (-2.80%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

MNVRX vs VFINX

Header iconMNVRX vs VFINX Comparison
Open Charts MNVRX vs VFINXBanner chart's image
Madison Investors R6
Price$30.90
Change-$0.89 (-2.80%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
MNVRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MNVRX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNVRX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. MNVRX (434M). VFINX pays higher dividends than MNVRX: VFINX (1.24) vs MNVRX (0.54). MNVRX was incepted earlier than VFINX: MNVRX (11 years) vs VFINX (48 years). MNVRX is a more actively managed with annual turnover of: 22.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than MNVRX: VFINX (0) vs MNVRX (500000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. MNVRX (12.16). VFINX return over 5 years is better than : 88.65 vs. MNVRX (29.48).
MNVRXVFINXMNVRX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years48 years-
Gain YTD19.37727.27571%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets434M1.37T0%
Annual Yield % from dividends0.541.2444%
Returns for 1 year12.1627.6344%
Returns for 3 years9.1130.9929%
Returns for 5 years29.4888.6533%
Returns for 10 years30.07193.6216%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc